IL2 and myalgic encephalomeyelitis/chronic fatigue syndrome: Of the three signalling molecules overlapping between ME/CFS, rituximab and Copaxone, we have chosen IL-2 as the major autocrine and paracrine T cell growth factor, which is, above all, responsible for the clonal expansion of antigen-specific T cells [42].